Macrogenics (MGNX) Misses Q1 EPS by 11c

Macrogenics (NASDAQ: MGNX) reported Q1 EPS of ($1.08), $0.11 worse than the analyst estimate of ($0.97). Revenue for the quarter came in at $2.06 million versus the consensus estimate of $5.56 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

You May Also Be Interested In

• Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
• Jefferies sees a buying opportunity in this S&P 500 sector
• Candel Therapeutics, Inc. (CADL) Misses Q2 EPS by 29c